197 related articles for article (PubMed ID: 16384583)
1. An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.
Venkatramani L; Bochkareva E; Lee JT; Gulati U; Graeme Laver W; Bochkarev A; Air GM
J Mol Biol; 2006 Feb; 356(3):651-63. PubMed ID: 16384583
[TBL] [Abstract][Full Text] [Related]
2. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5.
Lee JT; Air GM
Virology; 2006 Feb; 345(2):424-33. PubMed ID: 16297424
[TBL] [Abstract][Full Text] [Related]
3. N9 neuraminidase complexes with antibodies NC41 and NC10: empirical free energy calculations capture specificity trends observed with mutant binding data.
Tulip WR; Harley VR; Webster RG; Novotny J
Biochemistry; 1994 Jul; 33(26):7986-97. PubMed ID: 7517697
[TBL] [Abstract][Full Text] [Related]
4. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
[TBL] [Abstract][Full Text] [Related]
5. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
[TBL] [Abstract][Full Text] [Related]
6. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
Wan H; Gao J; Yang H; Yang S; Harvey R; Chen YQ; Zheng NY; Chang J; Carney PJ; Li X; Plant E; Jiang L; Couzens L; Wang C; Strohmeier S; Wu WW; Shen RF; Krammer F; Cipollo JF; Wilson PC; Stevens J; Wan XF; Eichelberger MC; Ye Z
Nat Microbiol; 2019 Dec; 4(12):2216-2225. PubMed ID: 31406333
[TBL] [Abstract][Full Text] [Related]
7. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.
Lee JT; Air GM
Virology; 2002 Sep; 300(2):255-68. PubMed ID: 12350356
[TBL] [Abstract][Full Text] [Related]
8. Interactions of protein antigens with antibodies.
Davies DR; Cohen GH
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):7-12. PubMed ID: 8552677
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.
Wan H; Yang H; Shore DA; Garten RJ; Couzens L; Gao J; Jiang L; Carney PJ; Villanueva J; Stevens J; Eichelberger MC
Nat Commun; 2015 Feb; 6():6114. PubMed ID: 25668439
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase.
Colman PM; Laver WG; Varghese JN; Baker AT; Tulloch PA; Air GM; Webster RG
Nature; 1987 Mar 26-Apr 1; 326(6111):358-63. PubMed ID: 2436051
[TBL] [Abstract][Full Text] [Related]
11. Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.
Kirkpatrick Roubidoux E; McMahon M; Carreño JM; Capuano C; Jiang K; Simon V; van Bakel H; Wilson P; Krammer F
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568453
[TBL] [Abstract][Full Text] [Related]
12. Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.
Rockman S; Camuglia S; Vandenberg K; Ong C; Baker MA; Nation RL; Li J; Velkov T
Mol Immunol; 2013 Apr; 53(4):435-42. PubMed ID: 23127859
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus.
Jiang H; Peng W; Qi J; Chai Y; Song H; Bi Y; Rijal P; Wang H; Oladejo BO; Liu J; Shi Y; Gao GF; Townsend AR; Wu Y
mBio; 2020 Oct; 11(5):. PubMed ID: 33024040
[TBL] [Abstract][Full Text] [Related]
14. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase.
Huang ZZ; Yu L; Huang P; Liang LJ; Guo Q
PLoS One; 2017; 12(7):e0178231. PubMed ID: 28708860
[TBL] [Abstract][Full Text] [Related]
15. The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
Malby RL; Tulip WR; Harley VR; McKimm-Breschkin JL; Laver WG; Webster RG; Colman PM
Structure; 1994 Aug; 2(8):733-46. PubMed ID: 7994573
[TBL] [Abstract][Full Text] [Related]
16. Antigenic variation of neuraminidase of human type A influenza (H3N2) viruses isolated in Berlin (West).
Werner J; Schudrowitz C; Köhler H
Zentralbl Bakteriol Orig A; 1975 Dec; 233(4):440-6. PubMed ID: 56831
[TBL] [Abstract][Full Text] [Related]
17. Crystals of antibodies complexed with influenza virus neuraminidase show isosteric binding of antibody to wild-type and variant antigens.
Laver WG; Webster RG; Colman PM
Virology; 1987 Jan; 156(1):181-4. PubMed ID: 3811232
[TBL] [Abstract][Full Text] [Related]
18. Epitope peptides of influenza H3N2 virus neuraminidase gene designed by immunoinformatics.
Liang L; Huang P; Wen M; Ni H; Tan S; Zhang Y; Chen Q
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):113-8. PubMed ID: 22107789
[TBL] [Abstract][Full Text] [Related]
19. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Stadlbauer D; McMahon M; Turner HL; Zhu X; Wan H; Carreño JM; O'Dell G; Strohmeier S; Khalil Z; Luksza M; van Bakel H; Simon V; Ellebedy AH; Wilson IA; Ward AB; Krammer F
Nat Commun; 2022 Dec; 13(1):7864. PubMed ID: 36543789
[TBL] [Abstract][Full Text] [Related]
20. Immunity to influenza.
Schild GC; Oxford JS; Virelizier JL
Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
